Wordt geladen...
Targeting DNA Mismatches with Rhodium Metalloinsertors
DNA has been exploited as a biological target of chemotherapeutics since the 1940s. Traditional chemotherapeutics, such as cisplatin and DNA-alkylating agents, rely primarily on increased uptake by rapidly proliferating cancer cells for therapeutic effects, but this strategy can result in off-target...
Bewaard in:
| Gepubliceerd in: | Inorganica Chim Acta |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5061454/ https://ncbi.nlm.nih.gov/pubmed/27746507 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ica.2016.01.021 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|